Verity Asset Management’s Novo Nordisk NVO Stock Holding History

Verity Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$539K	Buy	11,240 +315	+3%	+$13.5K	0.2%	131
2026 Q1	$401K	Sell	10,925 -1,151	-10%	-$54.5K	0.17%	146
2025 Q4	$614K	Sell	12,076 -28,420	-70%	-$1.45M	0.26%	104
2025 Q3	$2.25M	Buy	+40,496	New	+$2.37M	0.73%	34

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Verity Asset Management's NVO Position: Q2 2026 in Review

Verity Asset Management increased its Novo Nordisk (NVO) stake by 2.9% in Q2 2026, buying an estimated $13.5K and bringing the position to 11,240 shares worth $539K. The position accounts for 0.2% of the portfolio, ranked #131.

Verity Asset Management first reported a position in NVO in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.25M in Q3 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Verity Asset Management held 11,240 shares of Novo Nordisk worth $539K as of Q2 2026.
Verity Asset Management bought 315 Novo Nordisk shares in Q2 2026, an estimated $13.5K.
Novo Nordisk made up 0.2% of Verity Asset Management's portfolio in Q2 2026, its #131 holding.
Verity Asset Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 4 quarters since.
Verity Asset Management's Novo Nordisk position peaked at $2.25M in Q3 2025.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Verity Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.